Cerundolo V - Search Results

1

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

Prota G, Gileadi U, Rei M, Lechuga-Vieco AV, Chen JL, Galiani S, Bedard M, Lau VWC, Fanchi LF, Artibani M, Hu Z, Gordon S, Rehwinkel J, Enríquez JA, Ahmed AA, Schumacher TN, Cerundolo V. Prota G, et al. Among authors: cerundolo v. Cancer Immunol Res. 2020 May;8(5):685-697. doi: 10.1158/2326-6066.CIR-19-0467. Epub 2020 Mar 23. Cancer Immunol Res. 2020. PMID: 32205315

2

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.

Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. Ogg GS, et al. Among authors: cerundolo v. J Exp Med. 1998 Sep 21;188(6):1203-8. doi: 10.1084/jem.188.6.1203. J Exp Med. 1998. PMID: 9743539 Free PMC article.

3

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Dunbar PR, Chen JL, Chao D, Rust N, Teisserenc H, Ogg GS, Romero P, Weynants P, Cerundolo V. Dunbar PR, et al. Among authors: cerundolo v. J Immunol. 1999 Jun 15;162(12):6959-62. J Immunol. 1999. PMID: 10358133

4

IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Sewell AK, Price DA, Teisserenc H, Booth BL Jr, Gileadi U, Flavin FM, Trowsdale J, Phillips RE, Cerundolo V. Sewell AK, et al. Among authors: cerundolo v. J Immunol. 1999 Jun 15;162(12):7075-9. J Immunol. 1999. PMID: 10358150

5

Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes.

Gileadi U, Gallimore A, Van der Bruggen P, Cerundolo V. Gileadi U, et al. Among authors: cerundolo v. Eur J Immunol. 1999 Jul;29(7):2213-22. doi: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8. Eur J Immunol. 1999. PMID: 10427984 Free article.

6

T cells work together to fight cancer.

Cerundolo V. Cerundolo V. Curr Biol. 1999 Sep 23;9(18):R695-7. doi: 10.1016/s0960-9822(99)80442-4. Curr Biol. 1999. PMID: 10508600 Free article. Review.

7

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.

Gileadi U, Moins-Teisserenc HT, Correa I, Booth BL Jr, Dunbar PR, Sewell AK, Trowsdale J, Phillips RE, Cerundolo V. Gileadi U, et al. Among authors: cerundolo v. J Immunol. 1999 Dec 1;163(11):6045-52. J Immunol. 1999. PMID: 10570292

8

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.

Youde SJ, Dunbar PR, Evans EM, Fiander AN, Borysiewicz LK, Cerundolo V, Man S. Youde SJ, et al. Among authors: cerundolo v. Cancer Res. 2000 Jan 15;60(2):365-71. Cancer Res. 2000. PMID: 10667589

9

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.

Mackensen A, Herbst B, Chen JL, Köhler G, Noppen C, Herr W, Spagnoli GC, Cerundolo V, Lindemann A. Mackensen A, et al. Among authors: cerundolo v. Int J Cancer. 2000 May 1;86(3):385-92. doi: 10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t. Int J Cancer. 2000. PMID: 10760827 Free article. Clinical Trial.

10

Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.

Oelke M, Moehrle U, Chen JL, Behringer D, Cerundolo V, Lindemann A, Mackensen A. Oelke M, et al. Among authors: cerundolo v. Clin Cancer Res. 2000 May;6(5):1997-2005. Clin Cancer Res. 2000. PMID: 10815925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page